ID

27542

Description

Study Part: Investigator’s Statement Follow-Up. An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Keywords

Versions (1)
  1. 11/20/17 11/20/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

November 20, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Investigator’s Statement Follow-Up Ropinirole Parkinson Disease 101468/165

English

Investigator’s Statement Follow-Up

1 forms  
INVESTIGATOR’S STATEMENT
Description

INVESTIGATOR’S STATEMENT

Alias
UMLS CUI-1
C0008961
UMLS CUI-2
C1710187
Patient Number
Description

Patient Number

Data type

text

Alias
UMLS CUI [1]
C1830427
Centre Number
Description

Centre Number

Data type

text

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Check all Adverse Event forms are up to date and complete
Description

Adverse Event

Data type

boolean

Alias
UMLS CUI [1]
C0877248
Check that the Concomitant Medication form is up to date
Description

Concomitant Medication

Data type

boolean

Alias
UMLS CUI [1]
C2347852
Check that all appropriate pages are signed (thus indicating completion) and dated
Description

consent

Data type

boolean

Alias
UMLS CUI [1]
C1511481
Check that laboratory results are included
Description

laboratory results

Data type

boolean

Alias
UMLS CUI [1]
C1254595
I certify that the observations and findings are recorded correctly and completely in this CRF.
Description

complete

Data type

boolean

Alias
UMLS CUI [1]
C0205197
Investigator:
Description

Investigator

Data type

text

Alias
UMLS CUI [1]
C2826892
Date:
Description

Date

Data type

date

Alias
UMLS CUI [1]
C0011008
Back to the top of the page

Similar models

Investigator’s Statement Follow-Up

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
INVESTIGATOR’S STATEMENT
C0008961 (UMLS CUI-1)
C1710187 (UMLS CUI-2)
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Centre Number
Item
Centre Number
text
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
Adverse Event
Item
Check all Adverse Event forms are up to date and complete
boolean
C0877248 (UMLS CUI [1])
Concomitant Medication
Item
Check that the Concomitant Medication form is up to date
boolean
C2347852 (UMLS CUI [1])
consent
Item
Check that all appropriate pages are signed (thus indicating completion) and dated
boolean
C1511481 (UMLS CUI [1])
laboratory results
Item
Check that laboratory results are included
boolean
C1254595 (UMLS CUI [1])
complete
Item
I certify that the observations and findings are recorded correctly and completely in this CRF.
boolean
C0205197 (UMLS CUI [1])
Investigator
Item
Investigator:
text
C2826892 (UMLS CUI [1])
Date
Item
Date:
date
C0011008 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial